Pharmafile Logo
Pharmafocus logo
Advanced Search
apple_research_kit_presented_by_senior_vp_of_operations_jeff_williams_

Apple research apps to require ethics board approval

April 30, 2015
Sales and Marketing Apple, BMJ, FDA, GP, researchkit

New guidelines will require apps developed for Apple’s ResearchKit health platform to be approved by an independent ethics board. The …

News
Perrigo image

Perrigo bats away raised Mylan bid

April 30, 2015
Sales and Marketing Mylan, Perrigo, Teva, Vigodman, merger

Perrigo has rejected an updated $34.1 billion takeover bid from Mylan, whilst Teva has also written an open letter in …

News
NHS image

NHS ‘close to breaking point’

April 30, 2015
Medical Communications, Sales and Marketing BMJ, Godlee, Kings Fund, NHS, king's fund

England’s NHS is ‘stretched close to breaking point’ and the next five years are likely to be the most challenging …

News
abilify_bms_otsuka

FDA waves through generic BMS antipsychotic

April 30, 2015
Manufacturing and Production, Sales and Marketing Alembic, BMS, FDA, Hetero and Torrent Pharmaceuticals, Teva

The FDA has approved four generic versions of Bristol-Myers Squibb’s top selling Abilify, an atypical antipsychotic drug approved to treat …

News
giorgio_bruno

Recipharm appoints general manager for Italian unit

April 30, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Giorgio Bruno, Recipharm

Contract development and manufacturing organisation Recipharm has confirmed that Dr Giorgio Bruno has been appointed general manager of Recipharm Italia. In …

Appointment

Pharma accused of hiding behind regulation and undermining NICE

April 29, 2015
Medical Communications, Sales and Marketing NHS, NICE, Royal Society of Medicine, UK, brett wells, health, pharma

University of York health economists have argued that pharma regulation is not evidence-based, lacks accountability and undermines NICE. Writing in …

News
pfizer_building_side

Pfizer posts second consecutive quarterly income decline

April 29, 2015
Sales and Marketing 2015, Pfizer, Q1, first quarter

Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …

News
Merck image

Merck sales fall in Q1 despite new product lifts

April 29, 2015
Sales and Marketing Merck, Q1, Remicade

Merck’s sales were down in the first quarter of 2015 thanks to its consumer care divestment and increasing competition for …

News
GSK image

GSK shingles vaccine performs

April 29, 2015
Research and Development, Sales and Marketing GSK, GlaxoSmithKline, HZ/su, Merck, zostovax

GlaxoSmithKline’s HZ/su vaccine candidate for the prevention of shingles has demonstrated promising benefits across all age groups in a late-stage …

News
Merck image

Conference round-up: companies go big on hepatitis C at EASL

April 29, 2015
Sales and Marketing Bristol-Myers Squibb, EASL, Merck, daclatasvir, daklinza

Big pharma names posted favourable results for hepatitis C treatments as they jostled for position as market leaders at the …

News
andreas_reimer_

RSA hires two consultants in Germany

April 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Reimer, Ji Kwon, rsa

Executive search and interims firm RSA has appointed two consultants to its teams in the DACH region. Andreas Reimer (pictured) …

Appointment

Helping Nepal – SHL to Match Staff Donations

April 29, 2015
Sales and Marketing helping nepal, shl group, world vision

In immediate response to the devastating earthquake that left Nepal in ruins on April 25th, SHL quickly reached out to …

News
Press release
BMS image

BMS lifted by new products

April 28, 2015
Sales and Marketing BMS, NICE, Q1, eams, immuno-oncology and hepatitis C

New drugs have helped Bristol-Myers Squibb see a slight increase in sales for the first quarter of 2015. Total revenues …

News
celgene-logo

Celgene splashes out on cancer R&D firm

April 28, 2015
Research and Development, Sales and Marketing

Oncology specialists Celgene have made a $485 million outlay to buy Quanticel Pharmaceuticals, to increase its effort and investment in …

News
The BioIndustry Association's Steve Bates

UK ‘has ten years to become global biotech leader’

April 28, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

The UK should be home to ‘the third global cluster’ for biotech in the next 10 years, according to a …

News
teva_copy

M&A drama continues as Mylan rejects Teva

April 28, 2015
Sales and Marketing M&A, MA, Mylan, Perrigo, Teva, bids, generics, takeovers

Mylan has firmly rejected Teva’s acquisition bid, even though its own bid for Irish firm Perrigo has also been turned …

News
gilenya__novartis_multiple_sclerosis

Researchers hit out at ‘alarming’ increase in MS drug costs

April 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing

Researchers have hit out at the ‘alarming’ rise in the costs of disease-modifying treatments for multiple sclerosis, in a new …

News
EM HQ

Big-name generics among new CHMP recommendations

April 27, 2015
Sales and Marketing CHMP, EMA, European Medicines Agency, Lyrica, pregabalin

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended 11 new medicines for approval, among them several …

News
pillsphotos1

The Pharmafocus debate: Is the price of new hepatitis C treatments fair?

April 27, 2015
Research and Development, Sales and Marketing Doctors of the World, Drug pricing, EFPIA, Gilead, MSF, drug cost, hepatitis C, patents, sofosbuvir, sovaldi

YES – says Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), who argues that …

Feature
Opdivo

EMA approves BMS’ Opdivo for advanced skin cancer

April 27, 2015
Sales and Marketing BMS, Bristol-Myers Squibb, EMA, Merck, Yervoy, ipilimumab, keytruda, melanoma, nivolumab, opdivo, pembrolizumab, skin cancer

Bristol-Myers Squibb has earned a recommendation from the EMA for its cancer immunotherapy treatment Opdivo as a monotherapy for patients …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026